ViewRay

High precision MRI-guided radiation

ViewRay® Inc. (NASDAQ:VRAY) designs, manufactures, and markets the MRIdian® radiation therapy system to address the key limitations of existing external-beam radiation therapy technologies. MRIdian employs MRI-based technology to provide real-time imaging that defines the targeted tumour from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian allows physicians to record the level of radiation exposure that the tumour has received and adapt the prescription as needed.